Document is current
Any future updates will be listed below
-
Authors
Hautakangas, Heidi http://orcid.org/0000-0002-5585-6856
Winsvold, Bendik S. http://orcid.org/0000-0003-4171-8919
Ruotsalainen, Sanni E. http://orcid.org/0000-0002-1631-4069
Bjornsdottir, Gyda
Harder, Aster V. E. http://orcid.org/0000-0002-5477-7232
Kogelman, Lisette J. A. http://orcid.org/0000-0001-9782-7810
Thomas, Laurent F. http://orcid.org/0000-0003-0548-2486
Noordam, Raymond http://orcid.org/0000-0001-7801-809X
Benner, Christian
Gormley, Padhraig
Artto, Ville
Banasik, Karina http://orcid.org/0000-0003-2489-2499
Bjornsdottir, Anna
Boomsma, Dorret I. http://orcid.org/0000-0002-7099-7972
Brumpton, Ben M. http://orcid.org/0000-0002-3058-1059
Burgdorf, Kristoffer Sølvsten
Buring, Julie E.
Chalmer, Mona Ameri http://orcid.org/0000-0003-4609-1895
de Boer, Irene http://orcid.org/0000-0002-7261-762X
Dichgans, Martin http://orcid.org/0000-0002-0654-387X
Erikstrup, Christian http://orcid.org/0000-0001-6551-6647
Färkkilä, Markus
Garbrielsen, Maiken Elvestad
Ghanbari, Mohsen http://orcid.org/0000-0002-9476-7143
Hagen, Knut
Häppölä, Paavo
Hottenga, Jouke-Jan http://orcid.org/0000-0002-5668-2368
Hrafnsdottir, Maria G.
Hveem, Kristian
Johnsen, Marianne Bakke
Kähönen, Mika
Kristoffersen, Espen S. http://orcid.org/0000-0002-8999-5424
Kurth, Tobias http://orcid.org/0000-0001-7169-2620
Lehtimäki, Terho http://orcid.org/0000-0002-2555-4427
Lighart, Lannie http://orcid.org/0000-0002-6570-3319
Magnusson, Sigurdur H. http://orcid.org/0000-0001-6669-3071
Malik, Rainer
Pedersen, Ole Birger http://orcid.org/0000-0003-2312-5976
Pelzer, Nadine http://orcid.org/0000-0003-1763-5443
Penninx, Brenda W. J. H.
Ran, Caroline http://orcid.org/0000-0003-0239-9871
Ridker, Paul M.
Rosendaal, Frits R.
Sigurdardottir, Gudrun R.
Skogholt, Anne Heidi http://orcid.org/0000-0001-7466-0405
Sveinsson, Olafur A.
Thorgeirsson, Thorgeir E.
Ullum, Henrik
Vijfhuizen, Lisanne S.
Widén, Elisabeth
van Dijk, Ko Willems http://orcid.org/0000-0002-2172-7394
,
de Boer, Irene
van den Maagdenberg, Arn M. J. M.
,
,
Aromaa, Arpo
Belin, Andrea Carmine http://orcid.org/0000-0001-6668-3172
Freilinger, Tobias
Ikram, M. Arfan http://orcid.org/0000-0003-0372-8585
Järvelin, Marjo-Riitta http://orcid.org/0000-0002-2149-0630
Raitakari, Olli T.
Terwindt, Gisela M.
Kallela, Mikko
Wessman, Maija
Olesen, Jes http://orcid.org/0000-0002-6712-2702
Chasman, Daniel I. http://orcid.org/0000-0003-3357-0862
Nyholt, Dale R. http://orcid.org/0000-0001-7159-3040
Stefánsson, Hreinn http://orcid.org/0000-0002-9331-6666
Stefansson, Kari http://orcid.org/0000-0003-1676-864X
van den Maagdenberg, Arn M. J. M.
Hansen, Thomas Folkmann http://orcid.org/0000-0001-6703-7762
Ripatti, Samuli http://orcid.org/0000-0002-0504-1202
Zwart, John-Anker http://orcid.org/0000-0001-5721-0154
Palotie, Aarno http://orcid.org/0000-0002-2527-5874
Pirinen, Matti http://orcid.org/0000-0002-1664-1350
- License Information
-
More Information
Article History
Received: 12 January 2021
Accepted: 22 November 2021
First Online: 3 February 2022
Competing interests
: G.B., T.E.T., S.H.M., H.S. and K.S. are employees of deCODE genetics/Amgen. P.G. is a current employee and stockholder of GlaxoSmithKline but work was conducted while employed by Massachusetts General Hospital, Boston, MA, USA. T.F. reports possible competing interest for Electrocore (participation in clinical studies), Novartis (speakers’ honoraria, participation in advisory boards, participation in clinical studies), Teva (speakers’ honoraria, participation in advisory boards), Lilly (speakers’ honoraria, participation in clinical studies), and Bayer (speakers’ honoraria). M. Kallela has served on Advisory Boards for MSD and Allergan; has received funding for travel and/or speaker honoraria from MSD, Allergan, Teva, Novartis and Genzyme; has received compensation for producing educational material from Teva and Allergan; has received research support from Helsinki University Central Hospital; and holds stock/stock options and/or has received Board of Directors compensation from Helsinki Headache Center. T.K. reports having received honoraria from Eli Lilly, Newsenselab and Total for providing methodological advice and from the BMJ for editorial services. A.P. is the Scientific Director of the public–private partnership project FinnGen that has 12 industry partners that provide funding for the FinnGen project. V.A. has served on advisory board for Allergan, Lundbeck, Teva and Lilly. G.M.T. reports consultancy support from Novartis, Allergan, Lilly and Teva, and independent support from Dutch Organization for Scientific Research, the Dutch Heart & Brain Foundations, IRRF and Dioraphte. Other authors report no competing interests.
